Author: admin

Summary and key points: China’s first fifth-generation stealth fighter, the Chengdu J-20 Mighty Dragon, has raised suspicions that it borrows from American technology. – After its debut in 2011, questions emerged that the J-20’s rapid development may have been driven by espionage and technology theft. – China may have benefited from technology from the downed F-117 Nighthawk and intelligence from McDonnell Douglas’ Shanghai assembly plant. According to former Deputy Under Secretary of Defense Policy James Anderson, such espionage led to significant advances in the J-20, saving China time and resources. Chengdu J-20: China’s stealth fighter and the espionage debate The…

Read More

The state announced Friday that one of two finalist teams vying to be the master developer of the New Aloha Stadium Entertainment District has withdrawn. The sudden withdrawal of Waiola Development Partners without disclosing reasons has left only one consortium, Aloha Halawa District Partners, in the race to build a 25,000-seat stadium and surrounding residential and retail facilities on the former 98-acre Halawa site of the shuttered Aloha Stadium. The General Accounting Office and the Stadium Authority sought assurances in a news release that NASED’s request for proposals process would move forward and that the goal for opening the new…

Read More

As a health journalist, I often write about the hot topic of gut health, so when I noticed that a lot of gut experts were saying to aim to eat 30 different plants a week, I knew I had to give it a try, too.While there are a lot of fads in the health world that we should avoid, the idea of ​​eating 30 different plants a week for gut health came from a large-scale study called the American Gut Project, which was conducted in 2018. The study found that people who ate 30 different plants a week had a…

Read More

Banque Cantonale Vaudoise increased its holdings in Qifu Technology, Inc. (NASDAQ:QFIN – free report) by 94.3% during the first quarter, according to the latest filing with the SEC. The institutional investor bought an additional 100,000 shares during the quarter, bringing its holdings to 206,000 shares of the company’s stock. Banque Cantonale Vaudoise held approximately 0.13% of Qifu Technology, valued at $3,797,000, as of the end of the latest reporting period. Other large investors also recently bought and sold shares of QFIN. Parallel Advisors LLC increased its holdings in Qifu Technology by 83.9% in the fourth quarter. Parallel Advisors LLC now…

Read More

Cognizant Technology Solutions Inc. (NASDAQ:CTSH – Get Free Report ) shares surged in pre-market trading on Thursday. The stock opened at $67.56 after closing at $65.81 the previous day. Cognizant Technology Solutions shares last traded at $66.82 with trading volume of 270,265 shares. What Wall Street analysts are saying Several equities analysts have recently commented on CTSH shares. Susquehanna lowered their price target on Cognizant Technology Solutions from $80.00 to $78.00 and gave the company a “neutral” rating in a research note on Thursday, May 2nd. JPMorgan Chase & Co. lowered their price target on Cognizant Technology Solutions from $81.00…

Read More

Gilead Sciences (NASDAQ:GILD – Get Free Report) shares surged before the market opened on Thursday. The stock opened at $65.03 after closing at $63.15 the previous day. Gilead Sciences shares were last traded at $65.82 with trading volume of 1,876,508 shares. Analysts Set New Price Targets A number of analysts have commented on the company recently. Robert W. Baird reaffirmed their “neutral” rating on shares of Gilead Sciences with a $80.00 price target in a report on Thursday. TD Cowen lowered their price target on shares of Gilead Sciences from $90.00 to $85.00 and set a “buy” rating on the…

Read More

With Euro 2024 underway and the group stage reaching the halfway point, we can already start to see what the coming weeks of the tournament will bring. England, one of the favourites to win the tournament, is picking up points but not winning the hearts of fans, who are craving the aggressive football that Germany and Spain have shown in their last 16 appearances.With Croatia and Belgium already in a precarious position, and Albania and Serbia saving the match with late goals, there’s little to be said for the loss in terms of drama – plus the possibility of Kylian…

Read More

To understand why Canada has failed to criminally prosecute foreign collusion, old news reports from Washington provide a useful starting point.In 1981, a Canadian correspondent noted that Canada and the United States were on opposing paths when it came to using security intelligence for policing.The US tightened regulations while Canada relaxed them — remnants of that era remain in Ottawa’s ongoing scandals — and it’s unclear how much the upcoming law will change that.Some Canadians may have been surprised by reports earlier this month that politicians were knowingly or unwittingly cooperating with foreign governments to receive campaign assistance and overseas…

Read More

The male body has long been considered the norm in sports studies, but a new resource aims to change that.The Quebec Institute for Sport has published a new resource focused on the study of female athletes’ physiology — how their bodies work — that it hopes will improve the experiences of women in sport.It was prepared in collaboration with sports advocacy group Egale Action, whose director of gender equality, Sylvie Beliveau, said the document was the first of its kind in the canton.It is designed to help coaches, parents and athletes better understand the specific physiological challenges women face during…

Read More

Shares of Proteome Sciences plc (LON:PRM – Get Free Report) fell below its 200-day moving average during trading on Friday. The stock’s 200-day moving average is GBX 4.07 ($0.05), falling to a low of GBX 3.55 ($0.05). Proteome Sciences shares last traded at GBX 3.86 ($0.05) with trading volume of 364,200 shares. Price Performance of Proteome Science The stock has a market capitalization of £11.39 Million, a P/E ratio of -386.00 and a beta of -0.03. The company’s 50-day moving average is 3.70 GBX and its 200-day moving average is 4.07 GBX. Proteome Science Company Profile (Get your free report)…

Read More